The Abu Dhabi Biobank is a joint initiative between Abu Dhabi Health and M42.
It marks a significant milestone in Abu Dhabi’s healthcare landscape.
The biobank will house a collection of 100,000 umbilical cord blood samples and 5 million human biospecimens.
Abu Dhabi Biobank Key objectives:
- Accelerate medical breakthroughs:
The biobank will provide a rich resource for researchers to study various diseases and develop new treatments, including stem cell-based therapies. - Improve patient outcomes:
By facilitating access to personalized medicine, the biobank will enhance patient care and improve treatment success rates. - Reduce healthcare costs:
Early diagnosis and targeted therapies can lead to significant cost savings for healthcare systems. - Position Abu Dhabi as a global healthcare leader:
The biobank will contribute to the emirate’s reputation as a center for medical excellence and attract talent from around the world.
Key features
- State-of-the-art facility: The biobank is in a net-zero building in Masdar City, ensuring safe and secure storage of biospecimens.
- Advanced technologies: The biobank employs cutting-edge technologies for sample collection, processing, and storage.
- Robust ethical framework: The biobank adheres to stringent ethical guidelines to protect the privacy and rights of participants.
Dubai Municipality launched a smart marine scraper to collect floating waste in the creek and water canals in the emirate.
The scraper was produced and developed locally by Emirati hands. pic.twitter.com/XfFjBEkcCY
— UAE Voice (@uae_voiceeng) May 14, 2024
Benefits
- Enhanced research capabilities:
The biobank will provide researchers with access to a wealth of data and biospecimens, enabling them to conduct groundbreaking research. - Personalized medicine:
The biobank will facilitate the development of personalized medicine approaches, tailoring treatments to individual patients’ genetic and biological makeup. - Improved patient outcomes:
The biobank will improve patient outcomes and reduce mortality rates by enabling earlier diagnosis and more effective treatments. - Economic benefits:
The biobank will contribute to the growth of Abu Dhabi’s healthcare sector and attract investment in medical research and innovation.
Abu Dhabi Biobank is the first of its kind in the Middle East to integrate cord blood banking with a broader “pan-human” biofluid and tissue collection.
Moreover. It is expected to generate a dataset of up to 10,000 cancers with multi-omics and AI tissue analytics, creating a valuable resource for cancer research.
It also aims to support up to 3,500 local stem cell therapy transplants by 2033.
Read Also:
About Mohamed bin Zayed AI and Heriot-Watt Training Partnership
RAK Natural History Program is Part of UAE’s Year of Sustainability
